Bayer AG NA (BAYNN)

Mexico


	Symbol		Exchange		Currency
	BAYGN		Derived		EUR	Real-time
	BAYGn		Xetra		EUR	Delayed
	BAYNd		BATS Europe		EUR	Delayed
	BAYRY		OTC Markets		USD	Delayed
	0P6S		London		EUR	Real-time
	BAYNN		BIVA		MXN	Delayed
	BAYNN		Mexico		MXN	Delayed
	BAYG		Milan		EUR	Real-time
	BAYGn		Dusseldorf		EUR	Delayed
	BAYGn		Hamburg		EUR	Delayed
	BAYGn		TradeGate		EUR	Delayed
	BAYGn		Frankfurt		EUR	Delayed
	BAY1		Warsaw		PLN	Delayed
	BAYGn		Vienna		EUR	Real-time
	BAYG		Budapest		HUF	Delayed
	BAYN		Bucharest		RON	Delayed

Currency in MXN

Disclaimer

501.00

0.00(0.00%)

Closed15/07

Fair Value

Day's Range

501.00

501.00

52 wk Range

500.00

805.00

BAYNN Income Statement

Featured here, the Income Statement (earnings report) for Bayer AG NA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

43,545

41,400

44,081

50,739

47,637

Total Revenues Growth

+18.52%

-4.93%

+6.48%

+15.1%

-6.11%

Cost Of Revenues

16,423

15,727

17,045

18,886

19,746

Gross Profit

27,122

25,673

27,036

31,853

27,891

Gross Profit Growth

+14.57%

-5.34%

+5.31%

+17.82%

-12.44%

Gross Profit Margin %

62.28%

62.01%

61.33%

62.78%

58.55%

Other Operating Expenses, Total

20,142

18,701

19,561

22,732

20,092

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.74%	-7.15%	+4.6%	+16.21%	-11.61%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,282	4,884	5,326	6,168	5,835
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14,801	13,886	14,531	16,036	14,714
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	59	-69	-296	528	-457

Operating Income

6,980

6,972

7,475

9,121

7,799

Operating Income Growth

+63.97%

-0.11%

+7.21%

+22.02%

-14.49%

EBIT Margin %

16.03%

16.84%

16.96%

17.98%

16.37%

Net Interest Expenses

-1,395

-1,298

-584

-679

-650

Net Interest Expenses Growth

-28.93%

+6.95%

+55.01%

-16.27%

+4.27%

Interest Expense, Total

-1,689

-1,500

-930

-1,058

-1,134

Interest And Investment Income

294

202

346

379

484

Other Non Operating Expenses, Total

215

-210

-720

-1,213

-1,399

EBT, Excl. Unusual Items

5,800

5,464

6,171

7,229

5,750

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-2,769

-21,017

-4,122

-1,375

-497

EBT, Incl. Unusual Items

2,853

-17,250

2,046

4,670

-1,621

EBT, Incl. Unusual Items Growth

+51.27%

-704.63%

+111.86%

+128.25%

-134.71%

EBT, Incl. Unusual Items Margin

6.55

-41.67

4.64

9.2

-3.4

Income Tax Expense

443

-1,689

1,024

504

1,321

Net Income to Company

4,110

-10,487

1,022

4,166

-2,942

Minority Interest

-19

-8

-22

-16

1

Net Income

4,091

-10,495

1,000

4,150

-2,941

Net Income Growth

+141.36%

-356.54%

+109.53%

+315%

-170.87%

Net Income Margin %

9.39%

-25.35%

2.27%

8.18%

-6.17%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

2,391

-15,569

1,000

4,150

-2,941

Basic EPS - Continuing Operations

2.44

-15.85

1.02

4.22

-2.99

Basic EPS - Continuing Operations Growth

+66.76%

-750.67%

+106.42%

+315%

-170.87%

Diluted EPS - Continuing Operations

2.44

-15.85

1.02

4.22

-2.99

Diluted EPS - Continuing Operations Growth

+66.82%

-750.77%

+106.42%

+314.58%

-170.94%

Basic Weighted Average Shares Outstanding

981.69

982.42

982.42

982.42

982.42

Diluted Weighted Average Shares Outstanding

981.69

982.42

982.42

982.42

982.42

Dividend Per Share

2.8

2

2

2.4

0.11

Dividend Per Share Growth

0%

-28.57%

0%

+20%

-95.42%

EBITDA

10,810

10,030

10,877

12,705

11,331

EBITDA Growth

+51.29%

-7.22%

+8.44%

+16.81%

-10.81%

EBITDA Margin %